Home
VCYT
VCYT News

Latest Veracyte Inc. (VCYT) News on April 26, 2025

Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer

Business Wire

a day ago

Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer

Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting

Business Wire

4 days ago

Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting

Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release

Business Wire

5 days ago

Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

Investor's Business Daily

9 days ago

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

Should You Continue to Hold Veracyte Stock in Your Portfolio?

Zacks

9 days ago

Should You Continue to Hold Veracyte Stock in Your Portfolio?

Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025

Business Wire

10 days ago

Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term

Zacks

11 days ago

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term

Here's Why Veracyte (VCYT) is a Strong Growth Stock

Zacks

12 days ago

Here's Why Veracyte (VCYT) is a Strong Growth Stock

Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain?

Zacks

15 days ago

Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain?

Veracyte And 2 More Stocks That Might Be Trading Below Their Estimated Value

Simply Wall St.

16 days ago

Veracyte And 2 More Stocks That Might Be Trading Below Their Estimated Value

Veracyte (VCYT) Just Overtook the 20-Day Moving Average

Zacks

16 days ago

Veracyte (VCYT) Just Overtook the 20-Day Moving Average

Strength Seen in Veracyte (VCYT): Can Its 13.0% Jump Turn into More Strength?

Zacks

16 days ago

Strength Seen in Veracyte (VCYT): Can Its 13.0% Jump Turn into More Strength?

Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago

Zacks

16 days ago

Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago

Veracyte (VCYT) Introduces AI-Powered Cancer Detection – Faster and More Accurate Than Ever!

Insider Monkey

a month ago

Veracyte (VCYT) Introduces AI-Powered Cancer Detection – Faster and More Accurate Than Ever!

Veracyte (VCYT) Up 0.7% Since Last Earnings Report: Can It Continue?

Zacks

a month ago

Veracyte (VCYT) Up 0.7% Since Last Earnings Report: Can It Continue?

Wall Street Analysts Believe Veracyte (VCYT) Could Rally 35.05%: Here's is How to Trade

Zacks

a month ago

Wall Street Analysts Believe Veracyte (VCYT) Could Rally 35.05%: Here's is How to Trade

MT Newswires

a month ago

Veracyte Cancer Diagnostic Platform Shows Higher Specificity Than Blood Tests

New Data Demonstrate Accuracy of Veracyte’s Whole-Genome Sequencing-Based MRD Testing Platform for Muscle-Invasive Bladder Cancer

Business Wire

a month ago

New Data Demonstrate Accuracy of Veracyte’s Whole-Genome Sequencing-Based MRD Testing Platform for Muscle-Invasive Bladder Cancer

US High Growth Tech Stocks With Promising Potential

Simply Wall St.

a month ago

US High Growth Tech Stocks With Promising Potential

GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?

Zacks

a month ago

GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?

MT Newswires

a month ago

Craig-Hallum Initiates Veracyte at Buy With $45 Price Target

Veracyte Announces Eight Abstracts Highlighting Performance and Clinical Utility of Its Decipher and MRD Tests in Urologic Cancers To Be Presented at EAU25

Business Wire

a month ago

Veracyte Announces Eight Abstracts Highlighting Performance and Clinical Utility of Its Decipher and MRD Tests in Urologic Cancers To Be Presented at EAU25

Veracyte Stock Surges 45.6% in a Year: What's Driving the Rally?

Zacks

a month ago

Veracyte Stock Surges 45.6% in a Year: What's Driving the Rally?

Veracyte (VCYT) Surged on Reporting Strong Earnings

Insider Monkey

2 months ago

Veracyte (VCYT) Surged on Reporting Strong Earnings

Veracyte Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

2 months ago

Veracyte Full Year 2024 Earnings: EPS Misses Expectations

Veracyte's (NASDAQ:VCYT) Performance Is Even Better Than Its Earnings Suggest

Simply Wall St.

2 months ago

Veracyte's (NASDAQ:VCYT) Performance Is Even Better Than Its Earnings Suggest

Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom

Zacks

2 months ago

Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Veracyte Inc Earnings Call

MT Newswires

2 months ago

UBS Adjusts Veracyte Price Target to $49 From $46, Maintains Buy Rating

Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat

Zacks

2 months ago

Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat

Veracyte Inc (VCYT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

GuruFocus.com

2 months ago

Veracyte Inc (VCYT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

MT Newswires

2 months ago

Veracyte Q4 Non-GAAP Earnings, Revenue Rise; Shares Fall After-Hours

Veracyte (VCYT) Q4 Earnings and Revenues Beat Estimates

Zacks

2 months ago

Veracyte (VCYT) Q4 Earnings and Revenues Beat Estimates

Associated Press Finance

2 months ago

Veracyte: Q4 Earnings Snapshot

Veracyte Announces Fourth Quarter and Full Year 2024 Financial Results

Business Wire

2 months ago

Veracyte Announces Fourth Quarter and Full Year 2024 Financial Results

What To Expect From Veracyte Inc (VCYT) Q4 2024 Earnings

GuruFocus.com

2 months ago

What To Expect From Veracyte Inc (VCYT) Q4 2024 Earnings

Is Veracyte Stock a Good Addition to Your Portfolio Right Now?

Zacks

2 months ago

Is Veracyte Stock a Good Addition to Your Portfolio Right Now?

High Growth Tech Stocks To Watch In February 2025

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch In February 2025

Veracyte to Participate in Upcoming Investor Conferences

Business Wire

2 months ago

Veracyte to Participate in Upcoming Investor Conferences

Schrodinger Stock Scores IBD Rating Upgrade

Investor's Business Daily

2 months ago

Schrodinger Stock Scores IBD Rating Upgrade

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research

Business Wire

2 months ago

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research

Best Momentum Stocks to Buy for February 13th

Zacks

2 months ago

Best Momentum Stocks to Buy for February 13th

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU Symposium

Business Wire

2 months ago

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU Symposium

New Study Shows Veracyte’s Decipher Bladder Test Predicts Disease Upstaging in Patients with Bladder Cancer

Business Wire

3 months ago

New Study Shows Veracyte’s Decipher Bladder Test Predicts Disease Upstaging in Patients with Bladder Cancer

Veracyte to Release Fourth Quarter and Full-Year 2024 Financial Results on February 24, 2025

Business Wire

3 months ago

Veracyte to Release Fourth Quarter and Full-Year 2024 Financial Results on February 24, 2025

Zacks

3 months ago

Brian's Big Idea: Healthcare Stocks

MT Newswires

3 months ago

Needham Boosts Price Target on Veracyte to $51 From $44, Keeps Buy Rating

3 US Stocks Estimated To Be Undervalued By Up To 49.9% Presenting An Opportunity

Simply Wall St.

3 months ago

3 US Stocks Estimated To Be Undervalued By Up To 49.9% Presenting An Opportunity

Exploring High Growth Tech Stocks in January 2025

Simply Wall St.

3 months ago

Exploring High Growth Tech Stocks in January 2025

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues

Zacks

4 months ago

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues

Veracyte, Inc. (NASDAQ:VCYT) Has Found A Path To Profitability

Simply Wall St.

4 months ago

Veracyte, Inc. (NASDAQ:VCYT) Has Found A Path To Profitability

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks

Zacks

4 months ago

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks

Veracyte Gains 44% in a Year: What's Driving the Stock?

Zacks

4 months ago

Veracyte Gains 44% in a Year: What's Driving the Stock?

Macroeconomic Woes, FX Headwind Drag NEOG Stock Down

Zacks

4 months ago

Macroeconomic Woes, FX Headwind Drag NEOG Stock Down

Phibro Animal Health Gains 83% in a Year: What's Driving the Stock?

Zacks

4 months ago

Phibro Animal Health Gains 83% in a Year: What's Driving the Stock?

Should You Retain Labcorp Stock in Your Portfolio Right Now?

Zacks

4 months ago

Should You Retain Labcorp Stock in Your Portfolio Right Now?

Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now

Zacks

4 months ago

Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now

The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories

Zacks

4 months ago

The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories

Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?

Zacks

4 months ago

Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?

4 Healthcare Technology Innovators to Invest in Before the New Year

Zacks

4 months ago

4 Healthcare Technology Innovators to Invest in Before the New Year

The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte

Zacks

4 months ago

The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte

3 Medical Instruments Industry Stocks to Buy on the GenAI Wave

Zacks

4 months ago

3 Medical Instruments Industry Stocks to Buy on the GenAI Wave

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.

4 months ago

Exploring Three High Growth Tech Stocks In The United States

US Exchange: 3 Stocks That May Be Trading Below Fair Value

Simply Wall St.

4 months ago

US Exchange: 3 Stocks That May Be Trading Below Fair Value

Why Veracyte, With 55% Growth In 2024, Is An Outlier In Cancer Diagnostics

Investor's Business Daily

4 months ago

Why Veracyte, With 55% Growth In 2024, Is An Outlier In Cancer Diagnostics

Veracyte (VCYT) Shares Rebounded in Q3

Insider Monkey

4 months ago

Veracyte (VCYT) Shares Rebounded in Q3

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen

Zacks

4 months ago

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen

Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68%

Simply Wall St.

4 months ago

Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68%

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

Zacks

5 months ago

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now

Zacks

5 months ago

If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now

5 Medical Device Stocks That Survived the 2024 Market Volatility

Zacks

5 months ago

5 Medical Device Stocks That Survived the 2024 Market Volatility

Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines

Business Wire

5 months ago

Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines

MT Newswires

5 months ago

Goldman Sachs Downgrades Veracyte to Neutral From Buy, Trims Price Target to $37 From $38

Four Reasons To Watch This AI Play. A Fresh Breakout Is Just One.

Investor's Business Daily

5 months ago

Four Reasons To Watch This AI Play. A Fresh Breakout Is Just One.

MT Newswires

5 months ago

Morgan Stanley Lifts Price Target on Veracyte to $28 From $26, Keeps Underweight Rating

MT Newswires

5 months ago

Wolfe Research Initiates Veracyte at Outperform With $50 Price Target

MT Newswires

5 months ago

Veracyte Insider Sold Shares Worth $585,663, According to a Recent SEC Filing

High Growth Tech Stocks To Watch In November 2024

Simply Wall St.

5 months ago

High Growth Tech Stocks To Watch In November 2024

US Stocks Possibly Trading Below Fair Value Estimates In November 2024

Simply Wall St.

5 months ago

US Stocks Possibly Trading Below Fair Value Estimates In November 2024

Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next

Simply Wall St.

6 months ago

Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next

Veracyte Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

6 months ago

Veracyte Third Quarter 2024 Earnings: Beats Expectations

MT Newswires

6 months ago

UBS Adjusts Price Target on Veracyte to $46 From $43, Maintains Buy Rating

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised

Zacks

6 months ago

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised

Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook

GuruFocus.com

6 months ago

Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook

Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates

Zacks

6 months ago

Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates

Associated Press Finance

6 months ago

Veracyte: Q3 Earnings Snapshot

Veracyte Announces Third Quarter 2024 Financial Results

Business Wire

6 months ago

Veracyte Announces Third Quarter 2024 Financial Results

What To Expect From Veracyte Inc (VCYT) Q3 2024 Earnings

GuruFocus.com

6 months ago

What To Expect From Veracyte Inc (VCYT) Q3 2024 Earnings

Veracyte to Participate in Upcoming Investor Conferences

Business Wire

6 months ago

Veracyte to Participate in Upcoming Investor Conferences

Paragon 28, Inc. (FNA) Stock Jumps 7.2%: Will It Continue to Soar?

Zacks

6 months ago

Paragon 28, Inc. (FNA) Stock Jumps 7.2%: Will It Continue to Soar?

Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024

Business Wire

6 months ago

Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024

High Growth Tech Stocks To Watch In October 2024

Simply Wall St.

6 months ago

High Growth Tech Stocks To Watch In October 2024

MT Newswires

6 months ago

UBS Initiates Veracyte at Buy With $43 Price Target

Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 31% Discount?

Simply Wall St.

6 months ago

Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 31% Discount?

How to Find Strong Buy Medical Stocks Using the Zacks Rank

Zacks

7 months ago

How to Find Strong Buy Medical Stocks Using the Zacks Rank

MT Newswires

7 months ago

Guggenheim Initiates Veracyte at Buy With $40 Price Target

Veracyte Inc (VCYT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance

GuruFocus.com

7 months ago

Veracyte Inc (VCYT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance

Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today

Zacks

7 months ago

Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today

Vanguard Group Inc's Strategic Acquisition of Veracyte Inc Shares

GuruFocus.com

7 months ago

Vanguard Group Inc's Strategic Acquisition of Veracyte Inc Shares

New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men

Business Wire

7 months ago

New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men

Share on Social Networks: